In contrast, the percentage of paraplegia (65.2%) for MN-miR-155-KO mice (n = 23) was significantly lower (Chi-square: p = 0.0519; Fisher exact test: p = 0.0627) than that of control mice at 48-h post-ACC, indicating that miR-155 activity in MNs and other ChAT+ neurons increases the risk of developing paraplegia. The gene discussed is CHAT; the disease is paraplegia.